Soleno Therapeutics, Inc.
SLNO
$52.95
$0.020.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 148.45% | 111.88% | 40.19% | -176.84% | -280.98% |
| Total Depreciation and Amortization | 1.30% | 1.51% | 1.93% | 2.34% | 2.20% |
| Total Amortization of Deferred Charges | 337.50% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -55.97% | -50.90% | -8.74% | 437.69% | 648.84% |
| Change in Net Operating Assets | -1,684.67% | -509.32% | -393.73% | -16,223.53% | -147.91% |
| Cash from Operations | 218.15% | 167.73% | 49.64% | -96.79% | -190.57% |
| Capital Expenditure | 49.06% | 66.51% | 89.05% | -1,021.05% | -1,827.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -113.80% | 10.54% | 69.84% | 110.89% | 24.25% |
| Cash from Investing | -113.41% | 10.59% | 69.85% | 110.80% | 24.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 41.94% | 45.96% | -12.59% | -90.96% | -8.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,658.06% | -- | -- | -- | -- |
| Cash from Financing | -38.27% | -35.61% | 5.22% | -75.29% | 18.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.33% | 78.20% | 5,026.67% | -48.29% | 10.04% |